The purpose of this paper is to provide an update and report the current status of the cross-campus University of Colorado Denver program in bioinnovation and entrepreneurship, details of which were first reported in the Journal of Commercial Biotechnology in 20125.Â The paper outlines the joys and challenges of implementing an inter-campus program that attempts to marry cutting-edge biotechnology innovation with a solid business foundation.Â The tremendous value offered by such a program, particularly to biotechnology and life-science researchers, is outlined. Operationalization and process issues such as differential tuition rates, distance between campuses, and class timing issues are considered, and solutions are offered.Â Â Finally, recommendations are provided for other business schools considering a similar program.
Friedman, T. (2008) Hot, Flat, and Crowded: Why we need a Green Revolution--and how it can renew America. Farrar, Straus and Giroux; 1st edition.
Datar, S. M., Garvin, D. A., and Cullen, P. G. (2010). Rethinking the MBA: Business education at a crossroads. Harvard Business Press.
Pink, D.H. (2006) A whole new mind: Why right- brainers will rule the future. Riverhead Trade; Rep edition.
Meyers, A. D. and Hurley, P., (2008) Bioentrepreneurship education programmes in the United States, Journal of Commercial Biotechnology 14 (1): 1-12.
Parthasarathy, M., Forlani D., and Meyers, A. (2012) The university of Colorado certificate program in bioinnovation and entrepreneurship: an interdisciplinary, cross-campus model, Journal of Commercial Biotechnology, 18(1), 71-79.
Rogers, E. M. (2010). Diffusion of Innovations. Simon and Schuster.
Khuntia, J., Karimi, J., Tanniru, M., & Meyers, A. (2014) The University of Colorado Digital Health Consortium Initiative: A Collaborative Model of Education, Research and Service, Journal of Commercial Biotechnology, 20(3).
Unless specified by prior arrangement, the author agrees to the following terms and assurances:
- For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
- I/we further give to the following assurances
- I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
- I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
- To the best of my/our knowledge, all the facts in the contribution are true and accurate;
- The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
- Nothing in the contribution is obscene or libellous;
- Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
- I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).